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2352-345XBACKGROUND & AIMS: The genetic speciﬁcation of the com-
partmentalized pancreatic acinar/centroacinar unit is poorly
understood. Growth factor independence-1 (Gﬁ1) is a zinc
ﬁnger transcriptional repressor that regulates hematopoietic
stem cell maintenance, pre-T-cell differentiation, formation of
granulocytes, inner ear hair cells, and the development of
secretory cell types in the intestine. As GFI1/Gﬁ1 is expressed
in human and rodent pancreas, we characterized the potential
function of Gﬁ1 in mouse pancreatic development.
METHODS: Gﬁ1 knockout mice were analyzed at histological
and molecular levels, including qRT-PCR, in situ hybridization,
immunohistochemistry, and electron microscopy.
RESULTS: Loss of Gﬁ1 impacted formation and structure of the
pancreatic acinar/centroacinarunit. Histologic andultrastructural
analysis of Gﬁ1-null pancreas revealed speciﬁc defects at the level
of pancreatic acinar cells as well as the centroacinar cells (CACs)
in Gﬁ1/ mice when compared with wild-type littermates.
Pancreatic endocrine differentiation, islet architecture, and func-
tion were unaffected. Organ domain patterning and the formation
of ductal cells occurred normally during the murine secondary
transition (E13.5–E14.5) in the Gﬁ1/ pancreas. However, at
later gestational time points (E18.5), expression of cellular
markers for CACs was substantially reduced in Gﬁ1/ mice,
corroborated by electron microscopy imaging of the acinar/cen-
troacinar unit. The reduction in CACs was correlated with an
exocrine organ defect. Postnatally, Gﬁ1 deﬁciency resulted in se-
vere pancreatic acinar dysplasia, including loss of granulation,
autolytic vacuolation, and a proliferative and apoptotic response.
CONCLUSIONS: Gﬁ1 plays an important role in regulating the
development of pancreatic CACs and the function of pancreatic
acinar cells. (Cell Mol Gastroenterol Hepatol 2015;1:233–247;
http://dx.doi.org/10.1016/j.jcmgh.2014.12.004)
Keywords: Centroacinar Cells; Claudin 10; Growth Factor
Independence-1 (Gﬁ1).
he digestive functions of the pancreas are providedhttp://dx.doi.org/10.1016/j.jcmgh.2014.12.004
Tby acinar cells. Structurally, glandular acini consti-
tute the main mass of pancreatic parenchyma, organizedwithin pancreatic lobuli. Acini are composed of pyramid-
shaped cells that surround a centroacinar lumen. Drainage
of digestive juice is initially performed by a small duct that
is commonly referred to as the intercalated duct. The
intercalated ducts invaginate the acini, and the distal-most
cells of the intercalated ducts have been referred to as
centroacinar cells (CACs). Electron microscopy has allowed
for three-dimensional visualization of the acinar unit
structure, revealing that intercalated duct-type cells are not
obligatorily connected to the main ductal tree but may
intersperse within the larger acinar structure.
Acinar cells secrete directly into the luminal portion at
places lined with intercalated ductal cells. The developmental
origin of intercalated ductal cells has not been established,
but such are generally viewed as being thought to develop
from the identical origin as that of the main ductal tree, which
then would argue for an early developmental fate allocation
presumably occurring at the time of ductal fate assignment
in early embryogenesis.1 A general absence of markers to
distinguish between CACs and the intercalated duct cells of
the pancreas has not allowed a clear separation of the two cell
types, and studies investigating a possible differential, or
identical, origin of such cells through lineage tracing has not
been possible. Genetic components identifying the mecha-
nism of CACs development have not been found.2
Production of low protein/high bicarbonate ﬂuid by the
intercalated ductal cells and CACs helps to solubilize acinar
cell secretions, and the neutralizing effect of bicarbonate
helps to normalize pH in duodenum after gastric emptying.
Neutralization of pH locally may be important for neutral-
izing the content of exocrine secretory granules. Although
mature exocrine granules are at neutral pH, immature
granules are known to be acidiﬁed3 through the activity of
the vacuolar V-ATPase.4 Such granule acidiﬁcation is a
requirement for the pathological intracellular activation of
234 Qu et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 2zymogens that occurs after supramaximal cholecystokinin
or caerulein treatment,5,6 which eventually leads to acinar
cell death. The structural manifestation is one of intracel-
lular, acidiﬁed vacuoles in which cathepsin B catalyzes the
intracellular activation of zymogens. The insufﬁcient
neutralization of secretory juice is related to acinar disease.
For example, intraductal acidosis is a manifestation of acute
biliary pancreatitis.5,7
There is mounting evidence on the ontogeny of the major
pancreatic cell fates through genetic lineage tracing, but
knowledge of ductal cell-type speciﬁcation in the pancreas is
sparse.2,8 The major ductal population of the pancreas has
been shown to occur during a process referred to as organ
domain patterning, which preﬁgures the secondary transi-
tion and helps segregate multipotent pancreatic progenitor
cells into two distinct subsets, called trunk progenitor cells
(TrPCs) and tip progenitor cells (TipPCs). Notch signaling is
required for TrPC formation, and TipPC form upon Notch
signaling abrogation.9,10 Expression of speciﬁc transcription
factors is spatially controlled during TrPC/TipPC formation,
where Hnf1b (Tcf2), Hnf6 (Oc1), and Sox9 are expressed in
the TrPC population, in contrast to Ptf1a which is expressed
only by TipPC (as reviewed elsewhere8,11,12).
As Hnf1b, Hnf6, and Sox9 remain expressed in ductal
descendants of TrPC but are not expressed in endocrine
descendants, these markers are useful for tracking ductal
cell development. These factors are also expressed in
CACs, which are also dependent on Notch signaling.13–15
Therefore, it seems plausible that CACs are deﬁned as a
subpopulation of ductal descendants originating from the
TrPC population. However, it also remains possible that
TipPC acinar descendants could generate the CACs popu-
lation, if such could reactivate Notch signaling, which
subsequently could involve activation of the aforemen-
tioned intrinsic factors. The latter possibility is intriguing,
considering multiple reports of acinar cell plasticity
during adult organ regeneration, including reactivation of
Notch signaling.
We have observed that Gﬁ1 plays a role in the control of
the functional acinar/centroacinar cell unit. Gﬁ1 is critical
during hematopoiesis and inner ear cell development, and it
also plays a role in maintaining the functions of the lungs
and intestines.16–19 Gﬁ1 is expressed during development in
distalized pancreatic progenitors, corresponding to TipPC,
and remains expressed in acinar descendants. The absence
of Gﬁ1 does not abrogate acinar differentiation, and a
complement of all pancreatic lineages, including endocrine,
duct, and acinar cells, develops normally. However, after
differentiation of the exocrine pancreas of Gﬁ1 nulls, acinar
cells develop structural abnormalities in which they lose
apical polarity. Electron microscopy analysis of Gﬁ1-null
acinar cells has identiﬁed a general loss of rough endo-
plasmic reticulum (rER) associated with excessive cellular
content of immature secretory granules. Postnatally, Gﬁ1-
null exocrine cells become highly vacuolated. The exocrine
phenotype is characterized by a particular reduction of
CACs, as evidenced by an apparent elimination of the
expression of several markers such as Hnf6, Hnf1b, and Sox9
in the position of CACs. We conclude that Gﬁ1 is required forthe formation of CACs, and we believe Gﬁ1 is the ﬁrst factor
in forming the genetic requirements for creating and
maintaining the acinar/centroacinar structural unit.
Materials and Methods
Animals
The Gﬁ1þ/ mouse line (Gﬁ1tm1sho, MGI: 2449921) was
provided by Dr. Stuart Orkin. This targeting model contains
a deletion of exon 2–3.20 Vaginal plugs were checked the
next morning before 10:00 AM, and the time-mated em-
bryos were dissected as described elsewhere.21 The animals
were housed in the animal facility at the Cleveland Clinic. All
animal procedures and experiments were approved by the
Cleveland Clinic Animal Care and Use Committee.
Histology and Immunoﬂuorescence Analysis
Tissues were ﬁxed in 4% paraformaldehyde at 4C
overnight, were washed in 1 phosphate-buffered saline
(PBS), and were equilibrated in 30% sucrose before
embedding in optimal cutting temperature compound,
before the cryosectioning. The immunostaining protocol
was followed as described elsewhere.21 Antigen retrieval
was performed with a neutral-pH antigen-retrieval agent.
The tissue samples were stained with the primary
antibodies as detailed in Supplementary Table 1. For the
anti-HNF6 antibodies staining, the Tyramide Signal Ampli-
ﬁcation Fluorescence system was used (PerkinElmer,
Waltham, MA). Before applying the blocking reagents, the
tissue samples underwent peroxidase (3% in PBS) treat-
ment for 7 minutes. After incubating in the primary anti-
body (rabbit anti-HNF6) for overnight and being washed
with PBS for 3 times (5 minutes/wash), the slides were
incubated in biotinylated secondary antibody for 30 mi-
nutes at room temperature. After washing 3 times in
1PBS (5 minutes/wash), the slides were further incu-
bated in streptavidin-peroxidase conjugate for 15 minutes,
which was then followed by three washes (5 minutes/
wash). Then the slides were incubated in ﬂuorophore tyr-
amide (ampliﬁcation reagent) for 3 to 10 minutes, which
was followed by washing. Binding of the primary antibodies
was detected by immunoﬂuorescence by incubating with
Texas Red-, Cy2-, or aminomethylcoumarin-conjugated
secondary antibodies (Jackson ImmunoResearch Labora-
tories, West Grove, PA). After washing with 1PBS, tissue
samples were mounted (Slowfade Antifade kit; Molecular
Probes/Life Technologies, Eugene, OR).
Immunohistochemical analysis for cell apoptosis was
performed by using an in situ apoptosis detection kit with
TUNEL (terminal deoxynucleotidyl transferase-mediated
dUTP nick end labeling) according to the manufacturer’s
instructions (Roche, Indianapolis, IN). To evaluate the cell
proliferation, we intraperitoneally injected mice with bro-
modeoxyuridine (BrdU) (50 mg/g of body weight). Two
hours after the injection, the mice were dissected, and the
pancreas were ﬁxed and processed following the same
protocol as previously mentioned for immunoﬂuorescence
analysis. Images were obtained using either an Olympus
BX51 upright epiﬂuorescence microscope (Olympus
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2000R cooled CCD camera (QImaging, Surrey, British
Columbia, Canada) or a Leica SP5 confocal microscope
(Leica Microsystems, Buffalo Grove, IL). Morphometry was
done by measuring the number of positively stained cells
per unit area using ImagePro 4.1 software image analysis
system (Media Cybernetics, Rockville, MD).
In Situ Hybridization
The probe for the in situ hybridization analysis was
generated by using the digoxigenin (DIG) labeling kit from
Roche, according to the manufacturer’s protocol. The probe
was made from a linearized plasmid containing the Gﬁ1
cDNA fragment (pCR-Gﬁ1) and T7 polymerase for antisense
probes or T3 polymerase for sense probes by using the DIG
RNA labeling mix (Roche). In situ hybridization was per-
formed on frozen sections of 4% paraformaldehyde-ﬁxed
samples. After postﬁxation and protease treatment, sec-
tions were prehybridized at 65C for 3 hours, followed by
overnight hybridization with either antisense or sense
probes at 65C. The slides were then washed with 0.2SSC/
0.1% Tween 20 at 65C for 1 hour. Sections then were
blocked with 5% goat serum and 2% hybridization blocking
reagent (Roche) for subsequent overnight incubation with
an anti-DIG antibody conjugated with horseradish peroxi-
dase at 4C. After washing with 1PBS/0.1% Tween 20,
NBT (nitro-blue tetrazolium chloride)/BCIP (5-bromo-4-
chloro-30-indolyphosphate p-toluidine salt) (Roche) was
used for signal detection.
Glucose Tolerance Test
Age- (10-week-old) and sex-matched wild-type (WT)
(n ¼ 4) and Gﬁ1-null mice (n ¼ 3) were fasted for 16 hours.
Before the test, the animals were weighed, and their pre-
injection blood glucose levels were measured. Filter-
sterilized D-glucose (catalog no. G8270; Sigma-Aldrich, St.
Louis, MO) was injected intraperitoneally (1 g/kg body
weight), and blood was sampled at 0, 15, 30, 45, 60, 90, 120,
and 150 minutes after the injection. The blood glucose level
was measured with an Accu-Check Glucometer (Roche). The
data are shown as the mean ± standard deviation (SD).
Electron Microscopy Analysis
Mouse pancreas (at the age of E18.5 and 1 month) (WT,
n ¼ 5; Gﬁ1-null, n ¼ 4) were dissected, and small pieces
were immediately ﬁxed in 2% glutaraldehyde in 0.1 M
sodium cacodylate buffer containing 0.1 M sucrose and 3 mM
calcium chloride (CaCl2) (pH 7.4) at room temperature for 4
to 8 hours, then stored at 4C until further processing.
Specimens were rinsed in 0.15 M sodium cacodylate buffer
containing 3 mM CaCl2 (pH 7.4), were postﬁxed in 2%
osmium tetroxide in 0.07 M sodium cacodylate buffer con-
taining 1.5 mM CaCl2 (pH 7.4) at 4C for 2 hours, were
gradually dehydrated in ethanol, followed by acetone, and
then were embedded in Epon resin. Semi-thin sections were
cut and stained with toluidine blue and were used for light
microscopic analysis. Ultrathin sections (40–50 nm) were cut
and contrasted with 2% uranyl acetate followed by leadcitrate. The ultrathin sections were examined on a Philips
CS12/STEM transmission electron microscope (FEI Company,
Hillsboro, OR) at Cleveland Clinic Lerner Research Institute
Imaging Core. The total number of acini individually
observed were 28 for WT and 20 for Gﬁ1-null.
Quantitative Real-Time Polymerase
Chain Reaction
The embryonic and adult mouse pancreas at different
developmental stages was isolated in RNAlater (Promega,
Madison, WI). The total RNA were isolated and extracted by
using RNAeasy RNA extraction kit following the manufac-
turer’s manual (Qiagen, Valencia, CA). Total RNA extracted
were reverse transcribed to cDNA using the SuperScript
First-Strand Synthesis System based on the manufacturer’s
protocols (Invitrogen/Life Technologies, Carlsbad, CA).
Quantitative real-time polymerase chain reaction (qRT-PCR)
was performed with iQ SYBR Green Supermix (Bio-Rad
Laboratories, Hercules, CA) according to the manufacturer’s
instructions and the protocols described elsewhere.21 The
expression levels of genes tested were normalized to the
expression levels of the housekeeping gene Gapdh using the
DDCt method. Primer sets used were HNF1b (Tcf2), 50-cca
tcc tca aag agc tcc ag-30, 50-ctc cct ctg ggg gat att gt-30; HNF6
(OC1), 50-ctg tga aac tcc ccc agg ta-30, 50-ggt gat gat ggt gag
gga ac; Sox9, 50-tgc agc aca aga aag acc ac-30, 50-cag cgc ctt
gaa gat agc at-30; Ptf1a, 50-cag agg acc cca gaa aac tca-30, 50-
gtc aaa ggt gct tca gga aat c-30; and Gapdh, 50-tgc gac ttc aac
agc aac tc-30, 50-atg tag gcc cat gag gtc cac-30. The data are
shown as mean ± SD.
Statistical Analysis
Statistical analyses were performed using the Student
t test. P  .05 was considered statistically signiﬁcant.
Results
Expression of Gﬁ1 in the Developing
Mouse Pancreas
We ﬁrst analyzed expression of Gﬁ1 in the mouse
pancreas at different developmental stages by performing
qRT-PCR and in situ hybridization. From the mice embry-
onic stages of E12.5 to E16.5, Gﬁ1 mRNA were present in
pancreas (Figure 1A). At later stages of embryonic devel-
opment (E17.5–E18.5) and the postnatal stage (P0 and P6),
the Gﬁ1 mRNA expression level was statistically signiﬁ-
cantly increased (Figure 1A). Gﬁ1 was continuously
expressed in the adult pancreas (1 month old and 4 months
old, 1M and 4M).
To assess the cell-type speciﬁc expression of Gﬁ1, we
performed in situ hybridization on developing mouse
pancreas tissues (Figure 1B). At all stages analyzed, the
pancreatic mesenchymal tissue was devoid of Gﬁ1 expres-
sion, and the adjacent liver, containing hematopoietic cells,
served as a useful positive control (Figure 1B).
Gﬁ1 was expressed in E11.5 pancreatic epithelium. At
E14.5, when the pancreas progenitor population had
segregated into the TrPC/TipPC regions, and acinar and
Figure 1. Expression
proﬁle of Gﬁ1 in the
developing and post-
natal mouse pancreas.
(A) Quantitative real-time
polymerase chain reac-
tion analysis of the ex-
pression pattern of Gﬁ1
mRNA at the indicated
developmental stages in
the mouse: E12.5–E18.5
and postnatal (P0 and P6,
and insert in showing 1
month old and 4 months
old, 1M and 4M). Data
shown (n ¼ 3/time point)
are mean ± standard
deviation. (B) In situ hy-
bridization analysis of
the expression pattern of
Gﬁ1 mRNA in developing
mouse pancreas (E11.5,
14.5, 15.5, and 16.5).
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became restricted to “tip” regions, gradually being
excluded from the central domain—the “trunk” regions—
although the cells displaying intermediate levels of Gﬁ1
mRNA could still be detected (arrows in Figure 1B, E14.5).
At E15.5, Gﬁ1 expression was fully excluded from trunk-
located cells. At E16.5, Gﬁ1 remained abundantly
expressed in the cells at tips, and we observed a strict
boundary between Gﬁ1-expressing cells at the tip location
to adjacent epithelial Gﬁ1-negative cells (E16.5 in
Figure 1B). The abundance of Gﬁ1 mRNA in the post-
secondary transition pancreas is suggestive of a functional
role for Gﬁ1 in pancreas development at the late devel-
opmental stages.Acinar, but Not Endocrine, Defects in
Gﬁ1-Null Pancreas
To functionally investigate Gﬁ1 in pancreas, we bred for
Gﬁ1 nullizygous embryos and offspring using a global
deletion model of exon 2–3 of Gﬁ1. Null animals suffer from
severe neutropenia, loss of hearing, and a general growth
deﬁciency.16–19 Visual inspection of midgestational (E14.5),
and late-gestational (E18.5) endodermal organs revealed a
normal pancreatic size and gross appearance. Analysis ofhematoxylin and eosin (H&E)-stained tissue at the embry-
onic stage of E14.5 and E18.5 did not reveal major changes
in pancreatic morphology (Figure 2A–D). However, in adult
mice (4 months old, 4M), morphologic changes were
observed in the acinar compartment. The acinar architec-
ture was poorly organized, marked by the presence of
vacuolized structures within the acini (Figure 2F), when
compared to the WT littermates (Figure 2E). At all stages
studied, the pancreatic acinar morphology of Gﬁ1 hetero-
zygous mice was normal.
Considering that Gﬁ1 is expressed during the secondary
transition when endocrine cells form, we ﬁrst investigated
the development and function of pancreatic endocrine cells.
The presence and organization of pancreatic endocrine cells
were analyzed by immunoﬂuorescence analysis against
polypeptide hormones and chromogranin A. The presence
of pancreatic endocrine cell types was conﬁrmed by stain-
ing for insulin (b), glucagon (a), and ghrelin (ε) at E18.5.
The endocrine cells’ abundance and organization were
comparable to WT mice. The central core of insulin-positive
b-cells in the islets of Langerhans, surrounded by glucagon-
positive a-cells, was observed in both the WT (Figure 2I )
and Gﬁ1/ pancreas (Figure 2J).
No difference in the expression of Pdx1 was observed
in Gﬁ1/mice (Figure 2H). Pdx1was conﬁned to the nuclei of
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as observed in WT littermates (Figure 2G), and was less
abundantly expressed in acinar cells (arrows, Figure 2G andH).
Expression of ghrelin and the panendocrine marker
chromogranin A (ChromA) were identiﬁed in Gﬁ1/ mice(Figure 2L) as compared with WT mice (Figure 2K). We
found no evidence of increased proliferation in the endo-
crine compartment at E18.5 using the M-phase marker
pHH3 compared with WT (Figure 2I and J). Analysis of the
E14.5 pancreas revealed a normal onset of pancreatic
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with no apparent delay.
To assess adult b-cell function, we performed a glucose
tolerance test in adult (10-week-old) Gﬁ1-null mice and WT
littermates. The glucose clearing rate and fasting glycemic
levels of the Gﬁ1-nulls remained comparable to the age-
matched WT mice (Figure 2S). We have concluded that
Gﬁ1 is not essential for initiation of pancreatic endocrine
cell differentiation, endocrine subtype fate assignment, the
process of islet formation, or b-cell function.
The endocrine compartment remained normal, so we
turned our investigation to the formation and structure of
the acinar compartment. To more speciﬁcally deﬁne the
onset of the acinar pancreatic phenotype, we ﬁrst charac-
terized the forming acinar compartment at E14.5. The
initiation of acinar development can be visualized at E14.5
by the tip-cell expression of Ptf1a and the emergence of
Mist1, which is expressed only in maturing acinar cells. Both
these proteins were expressed at E14.5 in Gﬁ1-null mice
(Figure 3B and D) in a pattern similar to WT littermates
(Figure 3A and C). Using antibodies directed against
carboxypeptidase A1 (CPA1) and amylase at E18.5, we
found that the acinar compartment displayed similar
immunoreactivity in the acinar cytoplasm between Gﬁ1-null
and WT littermates. The acinar cells appeared to develop
normally in the Gﬁ1-null mouse pancreas prenatally, but
postnatally both CPA1 and amylase immunostaining
revealed abnormal acinar units at the age of 1 month (1M)
(Figure 3F and H) when compared with WT (Figure 3E
and G). In addition, the typical pyramidal, wedgelike shape
of individual acinar cells was lost in the Gﬁ1-null pancreas
(Figure 3F and H). Furthermore, BrdU staining and TUNEL
staining revealed increased cell proliferation (at E18.5) and
cell apoptosis (at 1-month-old) in the Gﬁ1-null pancreas
(Figure 2N and P) compared with WT littermates
(Figure 2M and O), which was made further evident by
quantitative analysis (Figure 2Q and R).
To better visualize the changes in the acinar/cen-
troacinar units at the ultrastructural level, we performed
transmission electronic microscopy analysis. Electron
micrographs (EM) of WT pancreas showed the regularFigure 2. (See previous page). Characterization of the Gﬁ1-n
null pancreas. At the embryonic stage of 14.5 and 18.5 (E14
morphology in Gﬁ1-null mice (B, D). However, at the age of 4 m
compartment (F). The acinar architecture was poorly organized a
acini (F) when compared with WT (E). (G–N) Immunohistochemic
develop normally in the Gﬁ1-null pancreas (H, J, L, N), compar
18.5. In the Gﬁ1-null pancreas, Pdx1 was conﬁned to the nuclei
in wild-type (WT) littermates (G) and in both WT and Gﬁ1 knocko
in G and H). (O, P) Analysis of cell apoptosis by TUNEL staini
observed (P) compared with WT littermates (O). (Q, R) Morphom
rate of WT and Gﬁ1-null pancreas. WT (n ¼ 5) and Gﬁ1-null (n
modeoxyuridine (BrdU) injection, immunostaining for BrdUþ c
(n ¼ 8) pancreas (1 month old) were analyzed for cell apoptosis
Graphs values are mean ± standard deviation (SD). ***P < .0
conducted in fasted adult (10-week-old) wild-type (WT) (n ¼ 4
glucose clearing rate at various time points (15, 45, 90, and 150
WT mice. Graph values are mean ± SD. (T, U) Quantitative rea
pattern of Ngn3 mRNA at the indicated developmental stagesdistribution of zymogen granules within the acinar cells
(Figure 4A and C), a regular lumen with well-organized
microvilli (Figure 4D), and the highly organized rER
(Figure 4E). In contrast, EM of Gﬁ1-null pancreas revealed
accumulated zymogen granules in the acinar units
(Figure 4B and F) and autolysosomes (arrows in
Figure 4B), a distorted lumen with disorganized microvilli
(Figure 4G), and accumulation of cell secretions (arrows in
Figure 4G). We noted a highly disorganized, excessively
dilated rER in Gﬁ1-null pancreas (Figure 4H). Furthermore,
EM revealed signiﬁcant disturbance to the apical region of
almost all acini in the Gﬁ1-null pancreas. This was evident
by the irregular apical surfaces, indentations between in-
dividual exocrine cells, and vacuoles (Figure 4F). The latter
likely resulted from intracellular activation of zymogens.
The ultrastructural analysis also revealed the presence of
CAC in WT (highlighted with a dotted line in Figure 5A),
surrounded by zymogen-rich acinar cells, with which they
share a lumen. In contrast to the WT pancreas, we noted
that cells of a CAC morphology (small, cytoplasm sparse)
and location (adjacent to the exocrine apical surface)
were difﬁcult to detect within the Gﬁ1-null pancreas
(Figure 5B).Gﬁ1 Is Required for Centroacinar Cell Formation
in Pancreas
To further investigate whether CACs were affected in
Gﬁ1-null mice, we performed an immunohistochemical
analysis to localize and characterize these cell types,
covering a larger ﬁeld than provided by EM imaging. We
chose to stain the pancreatic tissues by using ﬂuorescently
labeled Bauhinia purpurea lectin (BPL), a speciﬁc lectin that
we have found only labels the acinar lumen. BPL displays
little to no reactivity against pancreatic ductal cells. At
E18.5, when the acinar units are maturing, BPL reactivity is
highly restricted to the emerging acinar lumen (Figure 5C);
an increase in BPL reactivity is noted as the organ matures
(1M, Figure 5E). The BPL reactivity was completely absent
in the E18.5 Gﬁ1-null pancreas (Figure 5D). BPL reactivity
was disorganized and was observed with the distortedull pancreas. (A–F) H&E staining of wild-type (WT) and Gﬁ1-
.5 and E18.5), there were no major changes in pancreatic
onths (4M), morphologic changes were observed in the acinar
nd marked by the presence of vacuolized structures within the
al analysis of WT and Gﬁ1-null pancreas. The endocrine cells
ed with WT littermates (G, I, K, M) at the embryonic stage of
of pancreatic insulin-producing cells at E18.5 (H) as observed
ut pancreas less abundantly expressed in acinar cells (arrows
ng. In the Gﬁ1-null pancreas, increased apoptotic cells were
etric quantiﬁcation of the cell proliferation and cell apoptosis
¼ 9) pancreas (E18.5) were analyzed for proliferation by bro-
ells, and quantitative analysis (Q). WT (n ¼ 12) and Gﬁ1-null
via TUNEL staining and followed by quantitative analysis (R).
01. Scale bar: 50 mm. (S) Glucose tolerance test (GTT) was
) and Gﬁ1-null mice (n ¼ 3). Fasting glycemic levels and the
minutes) of Gﬁ1-nulls remained comparable to age-matched
l-time polymerase chain reaction analysis of the expression
(E18.5 and P6) in WT and Gﬁ1-null pancreas. *P < .01.
Figure 3. Exocrine defects in Gﬁ1-null mice. (A–D) Immunohistochemical analysis of Ptf1a (A, B) and MIST1 (C, D)
expression in WT and Gﬁ1-null pancreas. Immunostaining using antibodies directed against Ptf1a and MIST1 protein shows
that both of these proteins were expressed at E14.5 in Gﬁ1-null mice (B, D) in a pattern similar to WT littermates (A, C). (E–H)
Immunohistochemical analysis of the other exocrine cell markers carboxypeptidase A1 (CPA1) and amylase in WT and Gﬁ1-
null pancreas. Both CPA1 and amylase immunostaining revealed abnormal acinar units at the age of 1 month (1M) (F, H) when
compared with WT (E, G). Scale bar: 50 mm.
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(Figure 5F), reﬂecting the EM morphology.
We also used antibodies directed against Claudin10 and
Mucin1 (Muc1) to detect the morphology of acinar apical
membranes. Claudin10 is highly speciﬁc for the cells in
the CAC position (Figure 5G). This pattern in the pancreas
reﬂects the presence of Claudin10 in terminal tubules in the
murine submandibular gland.22 Claudin10 immunoreac-
tivity was lost in the Gﬁ1-null pancreas at E18.5 (Figure 5H).
At the postnatal stage (6 days after birth, P6), speciﬁc
defects were further observed at the level of pancreatic
CACs in Gﬁ1-null mice when compared with WT littermates
(Figure 5O and P). In the WT pancreas, Claudin10 protein
speciﬁcally localizes at the apical membranes of acinar cells
(arrows in Figure 5O), where the duct cells including Sox9þ
CACs (arrowheads, Figure 5O) interconnect with acinar
cells. However, in Gﬁ1-null mice, Claudin10 expression at
the apical membranes of acinar cells dramatically decreased
(arrows in Figure 5P), and Sox9þ CACs were rarely found
(arrowheads in Figure 5P).
To examine the topology of ductal structures in the
pancreatic tissues of Gﬁ1-null mice, we performed immu-
noﬂuorescent staining with antibodies directed against
Mucin1 (Muc1), a membrane protein expressed in the
epithelial cells lining glands and ducts in multiple organs.23
In the E18.5 WT pancreas, Mucin1 antibodies labeled all
cells of the ductal system, including intercalated ducts andCACs, showing the well-structured branching of the ductal
system and the radiations of small luminal areas (Figure 5I).
Gﬁ1-null pancreas contained intercalated ductal cells but
showed a lack of the terminal, radiating, branching struc-
tures as observed in WT (Figure 5J). The phenotype was
more pronounced at 1 month of age (1M) (Figure 5L)
compared with WT littermates (Figure 5K). Progression and
worsening of acinar structural defects continued over time;
at 4 months old (4M), the Mucin1-positive areas outlined
the extensive vacuoles observed in the Gﬁ1-null pancreas
(Figure 5N) compared with WT (Figure 5M).Gﬁ1 Deﬁciency Results in Acinar Degeneration
and Regeneration after Birth
We surmised that the ongoing deterioration of acinar
function might be paralleled by a compensatory regenera-
tive program. When compared with the WT (Figure 2O), we
found a prevalence of apoptotic cells (TUNEL-positive
staining) restricted to the pancreatic acinar compartment in
the Gﬁ1-null pancreas (Figure 2P). Correspondingly, there
was also an acinar-compartment-speciﬁc increased fraction
of cells in the S-phase, as detected by short-term BrdU la-
beling (Figure 2N). Such a signiﬁcant regenerative response
would suggest substantial adaptive responses from one or
more cell types in the pancreas, which could include
dedifferentiation and redifferentiation events of existing
Figure 4. Ultrastructural
changes of acinar cells in
Gﬁ1-null mice. (A–H)
Transmission electronic
microscopy analysis of WT
and Gﬁ1-null pancreas.
The electron micrograph of
the WT pancreas shows
the regular distribution of
normal zymogen granules
in the acinar units (A, C), a
regular lumen with well-
organized microvilli (D),
and a highly organized
rough endoplasmic reticu-
lum (rER) (C, E). However,
the electron micrograph of
Gﬁ1-null pancreas shows
the extensively accumu-
lated zymogen granules in
the acinar units (B, F) and a
distorted lumen with dis-
organized microvilli (G). In
addition, the accumulation
of cell secretions (red
arrows in G) were noted,
combined with highly dis-
organized, dilated rER
(F, H).
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injury,24,25 or alternatively could involve the activation of
genetic programs normally only observed during embryo-
genesis, such as Ngn3 reactivation.26 Expression of Ngn3
mRNA was not found to be increased at E18.5 or post-
natally (P6) in the Gﬁ1-null pancreas when compared with
WT littermates via qRT-PCR analysis (Figure 2T and U),
arguing against the reactivation of endocrine progenitor
cells. It is possible that Gﬁ1 would be required for facul-
tative replenishment on a continuous basis, explaining the
inability of the organ to recover; however, it is also possible
that the initial effect of Gﬁ1 loss led to a defective pancre-
atic structure from which regeneration was not possible,
regardless of the status of Gﬁ1. Further investigations into
this matter would demand an ability to perform a postnatal
rescue of Gﬁ1.Organ Domain Patterning and Ductal Cell
Differentiation Is Normal in Gﬁ1-Null Pancreas,
but Formation of Centroacinar Cells in Late
Gestation Is Impaired
The developmental origin of CACs is currently unre-
solved but has been speculated to be ductal, occurring fromSox9-expressing cells.27 Ductal cell differentiation is initi-
ated at the secondary transition in mice (E13.5–E14.5),
resulting from bipotential TrPC-type progenitors segre-
gating into endocrine and ductal cells. The Gﬁ1-null
pancreas displayed a normal distribution and amount of
HNF1b- and Sox9-expressing cells at E14.5 (Figure 6B, D, F,
and H) when compared with the WT littermates (Figure 6A,
C, E, G). Such cells coexpressed the ductal marker Dolichos
biﬂorus agglutinin (DBA) (Figure 6F and H), conﬁrming
their ductal identity. The HNF1b- and Sox9-expressing cells
comprised the entire forming ductal system and extended to
the forming acinar units (Figure 6B, D, F, and H), compa-
rable to the WT pancreas (Figure 6A, C, E, and G). We
conclude that the Gﬁ1-null pancreas initiated ductal devel-
opment appropriately, and that the organ underwent an
intact process of organ domain patterning between E11.5
and E13.5.
At E16.5, after completion of the secondary transition, a
normal complement of HNF1bþ, Sox9þ, DBAþ cells was
observed, extending throughout the ductal system (Figure 6J,
L, N, and P) compared with the WT pancreas (Figure 6I, K,M,
and O). However, at E18.5, HNF6þ, Sox9þ, and HNF1bþ
cells, proximal to acinar units and thus corresponding to a
centroacinar location, were reduced in the Gﬁ1-null pancreas
March 2015 Role of Gfi1 in Pancreatic Development 241(Figure 7B, B0, D, D0, F, and F 0) but were easily identiﬁable in
the WT pancreas based on their expression, spatial location,
and the typical centroacinar morphology of being cytoplasmsparse and containing ﬂattened nuclei (Figure 7A, A0, C, C 0, E,
and E0). Over time, the reduction of HNF6-, HNF1b-, and
Sox9-expressing CACs remained, and only few such cells
Figure 6. The pancreatic transcription factors HNF1b, Sox9, and HNF6 are normally expressed in Gﬁ1-null pancreas at
the stage of pancreatic secondary transition. (A–H) At E14.5, immunoﬂuorescence analysis revealed that the expression of
the pancreatic transcription factors HNF1b, Sox9, and HNF6 in Gﬁ1-null pancreas (B, D, F, H) was unchanged compared with
WT mice (A, C, E, G). (I–P) At E16.5, the expression pattern of the pancreatic transcription factors HNF1b, Sox9, and HNF6 in
the Gﬁ1-null pancreas (J, L, N, P) was comparable to that observed in WT mice (I, K, M, O).
242 Qu et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 2could be detected at the age of 1month (Figure 8B, B0,D,D0, F,
and F0) when compared with the WT littermates (Figure 8A,
A0, C, C0, E, and E0).Figure 5. (See previous page). Deﬁciency of centroacinar cel
of WT and Gﬁ1-null pancreas. In the WT pancreas, a single CAC
cells, with which they share a lumen (Lu) (A). In contrast to the W
of CACs immediately adjacent to the exocrine apical surface
Bauhenia purpurea lectin (BPL). BPL reactivity was completely
(C). BPL reactivity was disorganized and observed with the dist
(F). (G, H) Immunohistochemical analysis of Claudin10. The stai
pancreatic exocrine cells in Gﬁ1-nulls (H) when compared with W
In the E18.5 WT pancreas, Mucin1 antibodies labeled all cells o
showing the well-structured branching of the ductal system and
contained intercalated ductal cells but showed a lack of the term
phenotype was more pronounced at 1 month old (1M) (L) com
acinar structural defects continued over time; at 4 months ol
observed in the Gﬁ1-null pancreas (N) compared with WT (M).
nochemical analysis of Claudin10 and Sox9 demonstrates the de
In the WT pancreas, Claudin10 protein (arrows) speciﬁcally loca
cells including Sox9þ CACs (arrowheads) interconnect with acin
at apical membranes of acinar cells (arrows) dramatically decre
Scale bar: 50 mm.The reduced expression of these transcriptional factors
in Gﬁ1-null mice was further conﬁrmed by qRT-PCR for the
mRNA levels of these genes (Figure 7G). Interestingly, thels (CACs) in Gﬁ1-null pancreas. (A, B) Electron micrographs
(red dotted line) is surrounded by zymogen (z.g.)-rich acinar
T pancreas, in the Gﬁ1-null pancreas the structure consisting
was defective (B). (C–F) Immunohistochemical analysis of
absent in the E18.5 Gﬁ1-null pancreas (D) compared with WT
orted acinar units in the 1-month-old (1M) Gﬁ1-null pancreas
ning of Claudin10 was diminished at the apical membrane of
T (G). (I–N) Immunohistochemical analysis of Mucin1 (Muc1).
f the ductal system, including intercalated ducts and CACs,
the radiations of small luminal areas (I). The Gﬁ1-null pancreas
inal, radiating, branching structures observed in WT (J). The
pared with WT littermates (K). Progression and worsening of
d (4M), Muc1-positive areas outline the extensive vacuoles
(O, P) At the postnatal stage (6 days after birth, P6), immu-
fects in acinar apical membranes and CACs in Gﬁ1-null mice.
lizes at the apical membranes of acinar cells, where the duct
ar cells (O). However, in Gﬁ1-null mice, Claudin10 expression
ased, and Sox9þ CACs (arrowheads) were rarely found (P).
Figure 7. Loss of expression of centroacinar cell (CAC) regulatory factors in the E18.5 Gﬁ1-null pancreas. (A–F0)
Immunoﬂuorescence analysis of the CAC regulatory factors HNF6, Sox9, and HNF1b. At E18.5, HNF6þ, Sox9þ, and HNF1bþ
cells, proximal to acinar units, thus corresponding to a centroacinar location, were reduced in the Gﬁ1-null pancreas (B, B0, D,
D0, F, F0) but were easily identiﬁable in the WT pancreas based on their marker expression, spatial location, and the typical
centroacinar morphology of being cytoplasm sparse and containing ﬂattened nuclei (A, A0, C, C0, E, E0). Scale bar: 50 mm. (G)
Reduced expression of the pancreatic transcriptional factors (Hnf1b, Sox9, Hnf6, and Ptf1a) in the Gﬁ1-null pancreas was
identiﬁed by quantitative real-time polymerase chain reaction. Graph values are mean ± standard deviation.
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244 Qu et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 2expression of the acinar/progenitor expressed gene Ptf1a
was similarly reduced (Figure 7G), yet expression of the
acinar terminal marker gene bHLHb8, encoding MIST1,remained expressed at normal levels and was detectable
throughout the acinar cells in the Gﬁ1-null pancreas. The
MIST1 protein expression pattern in the Gﬁ1-null pancreas
March 2015 Role of Gfi1 in Pancreatic Development 245at 1 month old (1M) (Figure 8H, H0, J, and J0) did not appear
to be noticeably different when compared with WT litter-
mates (Figure 8G, G0, I, and I0). These data suggest that the
Gﬁ1-null pancreas fails to establish a CAC population and
that this process occurs between E16.5 and E18.5 in mice.
This time period correlates very well with the signiﬁcant
increase in Gﬁ1 gene expression between E17.5 and E18.5
(Figure 1A) in mouse development.Discussion
Here, we report that Gﬁ1 plays a role in late gestational
development of the mouse pancreas. The Gﬁ1-null pancreas
develops a speciﬁc phenotype related to the exocrine organ.
The phenotype manifests between E16.5 and E18.5 and is
correlated with a signiﬁcant activation of Gﬁ1 mRNA
abundance. The main hallmark of the pancreatic response to
a lack of Gﬁ1 is the apparent lack of the distal-most ductal
cell type in the organ, typically referred to as the CAC. Our
data reveal a general disturbance to the organization of the
acinar unit, impacting acinar cell polarity and resulting in a
speciﬁc deﬁciency reﬂected by ultrastructural changes
including internal vacuolization, expanded rER, and a
particular deﬁciency in the organization of the apical
cellular region.
The apical side of the acinar cell is normally connected to
the intercalated ductal network, allowing for effective
drainage of zymogens. We suggest that retention of zymo-
gens in the acinar cells, the dilation of the acinar rER, and
the loss of Claudin10 apical expression are secondary to the
structural defects resulting from a lack of CACs, although an
intrinsic role of Gﬁ1 in the acinar cell cannot be ruled out.
The apical deﬁciency of the acinar unit is signiﬁcant as it
appears to involve a gradual loss of HNF1b-, HNF6-, and
Sox9-expressing cells at the very tip of the ductal network.
However, the majority of the pancreatic ducts appear un-
affected by a lack of Gﬁ1, and importantly both the devel-
opment of the ductal lineage and the formation of a ductal
tree structure, which occurs well before E18.5, are normal.
How Gﬁ1 functions in the proper development of the
interface between the ductal tree and the acinar cells of
the pancreas is still unclear. Expression of Gﬁ1 ranges from
the hematopoietic and lymphoid system to the sensory
epithelia such as inner ear hair cells as well as in Purkinje
cells, lung and intestinal epithelial cells, and parts of the
central nervous system.17–20 Gene knockout studies have
shown that loss of Gﬁ1 affects pre-T-cell differentiation, the
development of granulocytes, the development and function
of dendritic cells, the development pulmonary of neuroen-
docrine cells, the integrity of inner ear hair cells, and the
proliferation, differentiation, speciﬁcation, and self-renewalFigure 8. (See previous page). Loss of expression of centro
pancreas. (A–F0) Immunoﬂuorescence analysis of HNF6, HNF1
transcriptional factors at the position of the CACs in the Gﬁ1-
comparing with the WT pancreas (A, A0, C, C0, E, E0). (G–J0) M
MIST1 protein expression in adult WT and Gﬁ1-null mice (1 mon
protein expression pattern was comparable between WT (G, G
noticeably disorganized in the Gﬁ1-null pancreas (J, J0) when cof hematopoietic stem cells.17–20 In the gut, Gﬁ1 serves as
a prodifferentiation factor that regulates the secretory
versus endocrine fate switch.18
Except for the demonstrated role of Gﬁ1 in the mainte-
nance of hematopoietic stem cells, most studies implicate a
speciﬁc role for Gﬁ1 in cell fate determination. Considering
that the pancreatic regulatory program shares multiple de-
terminants with that of the gut, it is tempting to speculate
that Gﬁ1 may operate also in the pancreas for the deter-
mination of cell fate, here speciﬁcally related to the gener-
ation of CACs. The pancreas is, similar to the gut, composed
of secretory and endocrine components. Considering that
Gﬁ1 in the gut plays a speciﬁc role opposed to Neurog3
(Ngn3) in facilitating the development of goblet and Paneth
cells,18 a possibility is that in the pancreas Gﬁ1 is involved in
differentiating a unique secretory cell type, the CACs, from
the ductal compartment at a late stage (E17.5–E18.5).
At this point, our data are insufﬁcient to prove which
role Gﬁ1 plays in CAC differentiation. It is currently unclear
whether the lineage origin of the CACs is ductal or acinar,
and experimental clariﬁcation would require lineage tracing
from either compartment into the CACs, preferably under
conditions in the absence or presence of the Gﬁ1 gene
function. Because of the known plasticity of the acinar cell
compartment in adult pancreatic regeneration, CACs might
descend from acinar cells. Although we used multiple
commercial and published18 antibody reagents to GFI1,
these attempts failed to provide convincing data on the cell-
type or spatial expression of GFI1 protein at the time of CAC
differentiation.
Of note, Gﬁ1 mRNA expression data determined by in
situ hybridization revealed a tip-cell (ie, acinar-fated)
expression of Gﬁ1 in early pancreatic development
(Figure 1B). It is thus possible that a subpopulation of
already speciﬁed acinar cells commit to a CAC fate via the
expression of Gﬁ1. Because multiple markers, such as HNF6,
HNF1b, and Sox9, are commonly expressed between ductal
cells and CACs, we hypothesize that Gﬁ1 expression oper-
ates to segregate the distal-most ductal cells into speciﬁc
CACs, and that in absence of Gﬁ1 such speciﬁcation fails.
However, it is also possible that existing acinar cells begin to
express the complement of these genes upon a CAC con-
version. Further study is needed to distinguish between
these two possibilities.
It is intriguing to speculate that Gﬁ1 may be related to
the maintenance of Notch signaling in the CACs, as it was
previously shown that conditional deletion of Rbpj in the
pancreas led to conversion of CACs into acinar cells.14
Importantly, Gﬁ1 has been shown to be required for the
ability of immature hematopoietic cells to competently
integrate Notch signaling.28acinar cell (CAC) regulatory factors in the adult Gﬁ1-null
b, and Sox9 reveals reduced or absent expression of these
null pancreas at the age of 1 month (1M) (B, B0, D, D0, F, F0)
IST1 protein expression remains in adult Gﬁ1-null pancreas.
th old, 1M) was analyzed by immunoﬂuorescence. The MIST1
0) and Gﬁ1-null pancreas (H, H0). However, BPL expression is
ompared with WT mice (I, I0). Scale bar: 50 mm.
246 Qu et al Cellular and Molecular Gastroenterology and Hepatology Vol. 1, No. 2Regardless of the outstanding question on CACs origin, it
is signiﬁcant that the Gﬁ1 model provides evidence that
there is a speciﬁc genetic function that helps create the
terminal ductal structures of the organ and that this event
happens well after the initial speciﬁcation of the ductal
lineage. The acinar/centroacinar unit has been referred to
as a highly specialized compartment, having a fenestrated
structure apical to the acinar cell that allows for effective
draining of acinar zymogens. Regulation of pH appears to be
important to immediately neutralize immature zymogen
granule content should they enter this very restricted and
limited space. Therefore, it perhaps is not unexpected that
genetic mechanisms operate to secure proper development
at this level, including the speciﬁcation of a uniquely func-
tioning cell—CAC—at the distal-most intercalated ductal
network.
Mechanistically, the function of Gﬁ1 in the pancreas is
not understood. The Gﬁ1 gene encodes a 55-kDa nuclear
repressor, recruiting histone deacetylases to target pro-
moters. At its C-terminus, it bears six typical C2H2-type
zinc-ﬁnger domains that mediate sequence-speciﬁc DNA
binding and the interaction with other proteins.29 At its
N-terminus, GFI1 has a 20-amino acid stretch that was
named the SNAG (Snail/Gﬁ-1) domain because it is also
found in the proteins Snail and Slug, which similarly have
repressor functions.29 Many interaction partners for GFI1
are known, mainly expressed within the hematopoietic
system.30 It is unclear whether these also represent
pancreatic partners for GFI1, so it remains unknown which
genomic regions are targeted by Gﬁ1 in the pancreas as well.
Among the possible Gﬁ1-repressed genes in the pancreas is
Ngn3, as Gﬁ1 and Ngn3 are antagonistic in the gut; however,
we did not observe an increase in endocrine cell formation
at E14.5 in the Gﬁ1-null pancreas or obtain any evidence of
endocrine cell differentiation at later stages or postnatally.
We believe that due to the late-gestational phenotype, Gﬁ1
repressor functions are more likely to be related to sup-
pression of the gene-activation programs in the duct or
acinar cells, allowing for their further speciﬁcation. Mecha-
nistic studies focused on Gﬁ1 may provide new insight to
the biology of the CACs.
It should be recognized that we cannot determine
whether the lack of Gﬁ1 leads to a complete block in the
differentiation of CACs. It remains possible that such cells
differentiate but lack expression of particular factors such as
possibly HNF6, HNF1b, Sox9, which could be necessary for
their structural program. In the absence of a speciﬁc inter-
calated ductal/CAC marker that would signify the presence
of such a partially speciﬁed subpopulation, it is difﬁcult to
conclude that the cells are completely absent or present in
another differentiated form. However, transmission electron
microscopy imaging leads us to conclude that there are
fewer cellular structures present in Gﬁ1-nulls at the apical
exocrine position that are not provided by the exocrine cells
themselves. We believe that the presence of structures
provided by such dysfunctional intercalated ductal cells
would be detected as a membrane lipid bilayer contribution
proximal to the acinar cell if partially differentiated cells
were present. Evidently, the acinar units in Gﬁ1-null micewere abnormal, and the loss of Claudin10 supported the
notion that tight junctions at the apical position of the
exocrine cells are defective in Gﬁ1-null pancreas.
In conclusion, we have reported on a novel gene in the
pancreas, Gﬁ1, which serves a late role in organ develop-
ment. These studies open a new window into understanding
an elusive aspect of pancreatic biology—the formation of
the CAC and the creation of a functional acinar unit. These
studies also invite further exploration of the possible role of
Gﬁ1 in pancreatic disease and suggest a potential avenue for
therapeutic intervention.References
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Supplementary Table 1. Information about Primary Antibodies and Lectin Dye
Antibody Species Source Product ID Lot No. Dilution
Anti-amylase Rabbit Sigma-Aldrich, St. Louis, MO A8273 077h9044 1:500
Anti-ghrelin Goat Santa Cruz Biotechnology, Santa Cruz, CA SC10368 F0105 1:200
Anti-chrom A Rabbit Abcam, Cambridge, MA ab17064 GR192521-1 1:250
Anti-glucagon Mouse Sigma-Aldrich ab10988 G2654 1:100
Anti-insulin Guinea pig Novo-Nordisk, Bagsvaerd, Denmark A0564 10057850 1:500
Anti-Pdx1 Goat Dr. C.V. Wright, Nashville, TN — — 1:2000
Anti-Sox9 Rabbit Millipore, Billerica, MA AB5535 2167153 1:2000
Anti-HNF6 Rabbit Santa Cruz Biotechnology sc-13050 C0310 1:50 (TSA)
Anti-pHH3 Rabbit Millipore 06-570 2066052 1:200
Anti-mucin 1 Hamster NeoMarkers, Fremont, CA HM-1630-P 1630P805A 1:200
Anti-BrdU Mouse BD Biosciences, San Jose, CA 347580 56065 1:100
Anti-CPA1 Mouse Abcam ab84999 GR107104-1 1:200
Anti-claudin10 Rabbit Abcam ab24792-100 455776 1:200
Anti-HNF1b Rabbit Santa Cruz Biotechnology sc-22840 I0205 1:100
Anti-E-cadherin Rat Invitrogen, Frederick, MD 131900 73650155 1:200
Fluorescein-Bauhenia Purpurea lectin Vector Labs, Burlingame, CA FL-1281 Q0910 1:100
Fluorescein-Dolichos Biﬂorus agglutinin Vector Labs FL-1031 W1130 1:100
TSA, tyramide-stimulated ampliﬁcation.
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